Senores Pharmaceuticals Limited has informed the Exchange regarding investment through Right Issue in Senores Pharmaceuticals Inc., Wholly Owned Subsidiary of the Company.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the exchange that it will raise funds through a Rights Issue to invest in its wholly owned US-based subsidiary, Senores Pharmaceuticals Inc. A rights issue allows existing shareholders to buy additional shares in proportion to their current holding, typically at a discounted price. The exact amount to be raised and the rights issue price have not been disclosed in this headline. This move is aimed at strengthening the company's US operations and expanding its international presence.
Existing shareholders will get an opportunity to increase their stake, but they may need to invest additional capital. If not subscribed, their shareholding could be diluted. Long-term, the investment supports the company's US growth strategy.